Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies (terminated appraisal)

Technology appraisal
Reference number: TA842
Published: 22 November 2022

Register as a stakeholder

History

Invitation to participate

Final scope (PDF 171 KB)

Published:

30 August 2022
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 313 KB)

Published:

30 August 2022
Equality impact assessment (Scoping) (PDF 125 KB)

Published:

30 August 2022
Final stakeholder list (PDF 187 KB)

Published:

15 September 2022

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 189 KB)

Published:

06 April 2022
Draft matrix post referral (PDF 188 KB)

Published:

06 April 2022